Publication Month: Jun 2022 | Report Code: TIPRE00023663 | No. of Pages: 176 | Category: Medical Device | Status: Published
Electrophysiology (EP) is a biomedical field that deals with studying electric activity in the body. It is also called invasive cardiac electrophysiology, a series of tests examining the heart's electrical activity. It is performed to assess the heart's electrical system or activity and is used to diagnose and treat heart rhythm disorders or arrhythmia. The test is performed using catheters and wire electrodes that measure electrical activity via blood vessels that enter the heart. The increase in cardiovascular disorders such as atrial fibrillation, atrial flutter, and others and a significant increase in the geriatric and obese population are the key factors driving the growth of the electrophysiology market. However, the high cost of electrophysiology devices and unfavorable reimbursement scenarios hamper the market growth.
The report offers insights and in-depth analysis of the electrophysiology market, emphasizing various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of global leading market players. It also includes the impact of the COVID-19 pandemic on the market across all regions. Due to the COVID-19 pandemic, many health authorities focused on pandemic-related care. They avoided human contact due to growing transmission and strain on healthcare resources by postponing elective surgeries, suspending outpatient clinics, and triaging employees involved in urgent care. Furthermore, many countries imposed restrictions on nonclinical staff's access to the facility and guests. Moreover, there was an increase in the prevalence of cardiovascular conditions among COVID-19 patients, which further created the demand for electrophysiology studies, which resulted in market growth. Recent COVID-19 guidelines for healthcare professionals suggested a focus on urgent care and triaging cases to postpone elective surgeries and clinic appointments, with a transition to virtual-based care when appropriate.
Moreover, many companies manufacturing electrophysiology devices focus on responding to emergencies through various strategies such as manufacturing PPEs for healthcare workers, distributing pharmaceutical drugs, and other activities. Further, in November 2020, Medtronic and the Medtronic foundation has committed the financial support of US$ 3.8 million on a global level to provide healthcare worker support in terms of food, operational support, mental health support, PPE kits, and others. Thus, the pandemic had a short-term negative impact on the electrophysiology market
The electrophysiology market is segmented into product, indication, and geography. By region, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.
|Market Size Value in||US$ 8,286.18 million in 2022|
|Market Size Value by||US$ 14,849.01 million by 2028|
|Growth rate||CAGR of 10.2% from 2022 to 2028.|
|No. of Pages||178|
|No. of Tables||57|
|No. of Charts & Figures||76|
|Historical data available||Yes|
|Segments covered||Product and Indication|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, affecting over ~886,000 new people in Europe each year. According to a report on the burden of atrial fibrillation, the number of people with AF is expected to increase by 70% of the population by 2030, and by 2050 Europe is expected to have the highest number of patients with AF. As per the Centers for Disease Control and Prevention (CDC), in the US, it is estimated that this number will increase to 12.1 million by 2030. According to a study published in the Medical Journal of Australia in August 2015, the number of patients over 55 years of age with AF in Australia is expected to grow from 328,562 in June 2014 to ~600,000 cases by 2034. As per BioSig Technologies' 2019 annual report, the number of ablation procedures worldwide was projected to increase from 973,220 in 2017 to 1,455,000 by 2022; within this category, complex ablations were expected to increase by 13.5% annually from 440,629 in 2017 to 830,390 by 2022. Thus, the rising incidence of these diseases is increasing the demand for electrophysiological (EP) procedures, thereby acting as a driver for the growth of the electrophysiology market.
Based on product, the global electrophysiology market is segmented into electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, access devices, and others. In 2022, the electrophysiology laboratory devices segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. However, the electrophysiology ablation catheters segment is expected to register the highest CAGR in the electrophysiology market during 2022–2028.
Based on indication, the electrophysiology market is segmented into atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and others. The atrial fibrillation segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period.
The electrophysiology market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand. In April 2022, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec) recently hosted a product launch event titled Elephant trunk for the heart: revival of the classic” for its Fontus Branched Surgical Stent Graft System; Fontus; which was held back-to-back with a seminar on the stented elephant trunk procedure. Twenty-one experts from 17 hospitals gathered virtually to share clinical data and information related to the application of Fontus, which attracted the attendance of over 5,000 viewers online.
By geography, the electrophysiology market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of the MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Abbott Laboratories; Biotronik, Inc.; Boston Scientific Corporation; CardioFocus; GE Healthcare; Koninklijke Philips N.V.; Johnson & Johnson Services, Inc.; Medtronic; MicroPort Scientific Corporation; and Siemens Healthineers AG is among the leading companies operating in the electrophysiology market.
The List of Companies - Electrophysiology market